Gansevoort, R. T., van Gastel, M. D., Chapman, A. B., Blais, J. D., Czerwiec, F. S., Higashihara, E., . . . Devuyst, O. (2019). Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease. Kidney Int.
Chicago-стиль цитированияGansevoort, Ron T., et al. "Plasma Copeptin Levels Predict Disease Progression and Tolvaptan Efficacy in Autosomal Dominant Polycystic Kidney Disease." Kidney Int 2019.
MLA-цитированиеGansevoort, Ron T., et al. "Plasma Copeptin Levels Predict Disease Progression and Tolvaptan Efficacy in Autosomal Dominant Polycystic Kidney Disease." Kidney Int 2019.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.